Silver Book Fact

There are currently 312 medicines in development for heart disease and stroke.

PhRMA. 2009 Report: Medicines in development for heart disease and stroke. Washington, D.C.: PhRMA; 2009. http://www.phrma.org/sites/default/files/653/heart_2009

Reference

Title
2009 Report: Medicines in development for heart disease and stroke
Publisher
PhRMA
Publication Date
2009
Authors
PhRMA
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • The projected economic value of eliminating deaths from stroke is $7.6 trillion.  
  • It is estimated that the number of quality-adjusted life-years achieved with each $1 million spent on antihypertensive drug therapy is between 20-50 to more than 200.  
  • The rise in beta-blocker treatment rates (34% since 1996) is proof that sustained attention and effective initiatives saves lives and improves quality of life.  
  • Effects of optimal anticoagulation among AFib patients
    If 50% of individuals with atrial fibrillation who do not receive prophylaxis were optimally anti-coagulated, 19,380 emboli would be prevented and $1.1 billion would be saved each year.  
  • Primary angioplasty reduces 30-day mortality risk by 34% to 50%.